Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buckner

Showing results (241-250 of 255) with videos related to

Pageof 26
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.
Nature Ecology & Evolution|July 14, 2022
Prolonged morphological expansion of spiny-rayed fishes following the end-CretaceousAva Ghezelayagh, Richard C Harrington, Edward D Burress, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled TrialThomas M Churilla, Karla V Ballman, Paul D Brown, et al.
JAMA Oncology|October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical TrialJoshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
Nature Communications|January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trialEvanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Cancer|December 10, 2021
Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)Jon C Tilburt, David Zahrieh, Joel E Pacyna, et al.
American Journal of Epidemiology|July 12, 2011
Associations of high-grade glioma with glioma risk alleles and histories of allergy and smokingDaniel H Lachance, Ping Yang, Derek R Johnson, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaErica H Bell, Peixin Zhang, Edward G Shaw, et al.
The American Journal of Managed Care|June 15, 2012
Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancersKeith C Bible, Robert C Smallridge, John C Morris, et al.
Pageof 26

Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.
Nature Ecology & Evolution|July 14, 2022
Prolonged morphological expansion of spiny-rayed fishes following the end-CretaceousAva Ghezelayagh, Richard C Harrington, Edward D Burress, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled TrialThomas M Churilla, Karla V Ballman, Paul D Brown, et al.
JAMA Oncology|October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical TrialJoshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
Nature Communications|January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trialEvanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Cancer|December 10, 2021
Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)Jon C Tilburt, David Zahrieh, Joel E Pacyna, et al.
American Journal of Epidemiology|July 12, 2011
Associations of high-grade glioma with glioma risk alleles and histories of allergy and smokingDaniel H Lachance, Ping Yang, Derek R Johnson, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaErica H Bell, Peixin Zhang, Edward G Shaw, et al.
The American Journal of Managed Care|June 15, 2012
Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancersKeith C Bible, Robert C Smallridge, John C Morris, et al.
Pageof 26